Core Viewpoint - Scientific Industries, Inc. will participate in the Lytham Partners Spring 2025 Investor Conference, hosting a webcast presentation and one-on-one meetings with investors on May 29, 2025 [1][2][3]. Company Overview - Scientific Industries, Inc. (OTCQB: SCND) is a provider of life science tools, designing, manufacturing, and marketing laboratory equipment, including the Vortex-Genie 2 Mixer and Torbal balances, as well as bioprocessing systems under the name DOTS [4]. - The company's products are primarily used for research in laboratories across universities, hospitals, pharmaceutical companies, medical device manufacturers, and pharmacies [4]. Subsidiary Information - Scientific Bioprocessing, Inc. (SBI), a subsidiary of Scientific Industries, focuses on digitally simplified bioprocessing, offering bioprocess sensors, actuators, and data analytics software to enhance monitoring and control of critical process parameters [5].

Core Insights - Scientific Industries, Inc. reported a 5% revenue growth in its Benchtop Lab Equipment Operations for Q1 2025, driven by the Genie and Torbal Divisions, with a notable increase in US-based customers [4][5][6] - Overall revenue for the first quarter decreased by 3% due to a significant decline in international sales, which fell by 33% [4][6] - The company secured $1.5 million in equity financing and reported a decreased net loss of $1.78 million, improving from a loss of $2.05 million in the same period last year [5][9] Financial Overview - Net revenues for Q1 2025 totaled $2.41 million, down from $2.48 million in Q1 2024, primarily due to a $182,600 decrease in Bioprocessing Systems Operations revenues [6][17] - Benchtop Laboratory Equipment revenues increased to $2.3 million, a 5% rise compared to $2.2 million in the prior year [5][17] - Bioprocessing Systems Operations revenues decreased by 58% to $133,500 from $316,100 in the previous year [5][17] Profitability Metrics - Gross profit for Q1 2025 was $1.02 million, slightly down from $1.04 million in Q1 2024, with a gross margin of 42.2%, up from 41.9% [7][17] - Operating expenses decreased by 9.7% to $2.83 million, attributed to cost-cutting measures implemented in fiscal 2024 [8][17] - The company reported a basic and diluted loss per share of $0.16, an improvement from $0.20 in the same quarter last year [9][17] Strategic Developments - The company is planning to scale its DOTS platform with the launch of a new optical pH sensor and high-performance liquid injection system in the second half of 2025 [4] - A peer-reviewed publication validated the DOTS Multiparameter platform, confirming its sensitivity and reliability compared to industry standards [4][5]

Core Points - Scientific Industries, Inc. will file a Form 10Q and issue a press release regarding its first quarter financial results for the period ending March 31, 2025, after the market close on May 13, 2025 [1] - A conference call is scheduled for May 14, 2025, at 11:00 AM Eastern Time to discuss the financial results [2] Company Overview - Scientific Industries, Inc. is a life science tool provider that designs, manufactures, and markets laboratory equipment, including the Vortex-Genie 2 Mixer and Torbal balances, as well as bioprocessing systems under the product name DOTS [4] - The company's products are primarily used for research purposes in laboratories across universities, hospitals, pharmaceutical companies, medical device manufacturers, and pharmacies [4] Subsidiary Information - Scientific Bioprocessing, Inc. (SBI), a subsidiary of Scientific Industries, focuses on digitally simplified bioprocessing, offering bioprocess sensors, actuators, and data analytics software to help monitor and control critical process parameters and product quality [5]